« Back
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
Nov 13, 2020
Presentation Details
Date:
Time:
Webcast: https://wsw.com/webcast/jeff141/tars/1861050
The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days.
In addition to the presentation, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Tarsus should contact their Jefferies representative.
About
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words, without limitation, “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms of the offering or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus that forms a part of the effective registration statement filed with the
Media Contact:
allison@pascalecommunications.com
Source: Tarsus Pharmaceuticals, Inc